Aberrant expression of T-plastin in Sezary cellsSU, Ming-Wan; DOROCICZ, Irene; DRAGOWSKA, Wieslawa H et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7122-7127, issn 0008-5472, 6 p.Article

Deficiency of SATB 1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcriptionYANG WANG; MINGWAN SU; ZHOU, Liang L et al.Blood. 2011, Vol 117, Num 14, pp 3826-3835, issn 0006-4971, 10 p.Article

CXCL13 Is Highly Produced by Sézary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 ChemokinesPICCHIO, Maria Cristina; SCALA, Enrico; BONOLDI, Emanuela et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 17, pp 7137-7146, issn 0008-5472, 10 p.Article

Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcriptsLEE, Carolyn S; UNGEWICKELL, Alexander; MEIHONG LIN et al.Blood. 2012, Vol 120, Num 16, pp 3288-3297, issn 0006-4971, 10 p.Article

Cucurbitacin I Inhibits Stat3 and Induces Apoptosis in Sézary CellsVAN KESTER, Marloes S; OUT-LUITING, Jacoba J; VON DEM BORNE, Peter A et al.Journal of investigative dermatology. 2008, Vol 128, Num 7, pp 1691-1695, issn 0022-202X, 5 p.Article

Large cell mycosis fungoides at the tumor stage. Unusual T8, T4, T6 phenotypic expressionHORIUCHI, Y; TONE, T; UMEZAWA, A et al.The American journal of dermatopathology. 1988, Vol 10, Num 1, pp 54-58, issn 0193-1091Article

Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome : Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokineRICHARDSON, Stephen K; NEWTON, Sarah B; BACH, Tami L et al.American journal of hematology. 2007, Vol 82, Num 9, pp 792-797, issn 0361-8609, 6 p.Article

Significance of circulating T-cell clones in Sézary syndromeORTONNE, Nicolas; HUET, Delphine; GAUDEZ, Caroline et al.Blood. 2006, Vol 107, Num 10, pp 4030-4038, issn 0006-4971, 9 p.Article

Les lymphomes T épidermotropes comme modèles de progression tumorale = Epidermotropic T cell lymphomas as models for tumor progressionBAGOT, Martine; BENSUSSAN, Armand.MS. Médecine sciences. 2006, Vol 22, Num 2, pp 192-196, issn 0767-0974, 5 p.Article

Relationship of t leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia : a cytogenetic analysis with in situ hybridizationBRITO-BABAPULLE, V; MALJAIE, S. H; MATUTES, E et al.British journal of haematology. 1997, Vol 96, Num 4, pp 724-732, issn 0007-1048Article

Glomerular disease and urinary Sézary cells in cutaneous T-cell lymphomasMOE, S. M; BARON, J. M; COVENTRY, S et al.American journal of kidney diseases. 1993, Vol 21, Num 5, pp 545-547, issn 0272-6386Article

Sézary cell count in exfoliative dermatitisKRISADA DUANGURAI; THADA PIAMPHONGSANT; THONGBAI HIMMUNGNAN et al.International journal of dermatology. 1988, Vol 27, Num 4, pp 248-252, issn 0011-9059Article

The emergence of Sézary cells during the treatment of cutaneous T-cell lymphomaSATO, M; ISHIKAWA, O; MIYACHI, Y et al.British journal of dermatology (1951). 1995, Vol 133, Num 5, pp 810-813, issn 0007-0963Article

Sezary cell-like leukemia: a distinct type of mature T cell malignancyMATUTES, E; KELLING, D. M; NEWLAND, A. C et al.Leukemia. 1990, Vol 4, Num 4, pp 262-266, issn 0887-6924Article

Nonneoplastic circulating Sézary-like cells in cutaneous T-cell lymphoma: ultrastructural, immunologic, and T-cell receptor gene-rearrangement studiesBENDELAC, A; O'CONNOR, N. T. J; DANIEL, M.-T et al.Cancer. 1987, Vol 60, Num 5, pp 980-986, issn 0008-543XArticle

The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in mycosis fungoides/Sézary syndrome cellsCHUNLEI ZHANG; XIAO NI; KONOPLEVA, Marina et al.Journal of investigative dermatology. 2004, Vol 123, Num 2, pp 380-387, issn 0022-202X, 8 p.Article

Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signalingNIKOLOVA, Maria; MUSETTE, Philippe; BAGOT, Martine et al.Blood. 2002, Vol 100, Num 3, pp 1019-1025, issn 0006-4971Article

Constitutive stat3-activation in Sezary syndrome: tyrphostin AG490 inhibits stat3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cellsERIKSEN, K. W; KALTOFT, K; MIKKELSEN, G et al.Leukemia. 2001, Vol 15, Num 5, pp 787-793, issn 0887-6924Article

Diminished CD3 expression is useful for detecting and enumerating Sézary cellsEDELMAN, Jeffrey; MEYERSON, Howard J.American journal of clinical pathology. 2000, Vol 114, Num 3, pp 467-477, issn 0002-9173Article

Sezary cell-like leukemia with atypical immunophenotypeORERO, M; MIGUEL-SOSA, A; MIGUEL-GARCIA, A et al.Leukemia. 1997, Vol 11, Num 8, pp 1383-1385, issn 0887-6924Article

Immunophenotypic identification of Sezary cells in peripheral bloodBOGEN, S. A; PELLEY, D; CHARIF, M et al.American journal of clinical pathology. 1996, Vol 106, Num 6, pp 739-748, issn 0002-9173Article

Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-β on the cell surfaceCHUNG, Jin-Sung; SHIUE, Lisa H; DUVIC, Madeleine et al.Blood. 2011, Vol 117, Num 12, pp 3382-3390, issn 0006-4971, 9 p.Article

Recherche de cellules de Sézary dans le sang périphérique : morphologie ou immunophénotype ? = Peripheral blood Sézary cells and the diagnosis of Sézary syndromeTESSIER-MARTEAU, A; LE CORRE, Y; GERARD, J et al.Annales de biologie clinique (Paris). 2008, Vol 66, Num 4, pp 447-453, issn 0003-3898, 7 p.Article

Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome : a potential role for bacterial superantigensTOKURA, Y; YAGI, H; OHSHIMA, A et al.British journal of dermatology (1951). 1995, Vol 133, Num 1, pp 6-12, issn 0007-0963Article